BioNexus Gene Lab CorpOTC Pink - Current Information:BGLC
- LAST PRICE0.5399
- TODAY'S CHANGE (%)-0.1099 (-16.9129%)
- Bid / Lots0.2600/ 40
- Ask / Lots0.5398/ 36
- Open / Previous Close0.2780 / 0.6498
- Day Range
- 52 Week Range
- Volume4,290
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | BGLC |
|---|---|---|
| 10:06 ET | 100 | 0.5399 |
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
BioNexus Gene Lab Corp | 112.9M | -843.6x | --- |
Streamline Health Solutions Inc | 98.2M | -8.9x | --- |
Mainz Biomed NV | 93.6M | -3.7x | --- |
Biodesix Inc | 134.9M | -1.1x | --- |
Enzo Biochem Inc | 111.2M | -3.2x | --- |
Talkspace Inc | 114.4M | -1.4x | --- |
Company Information
BioNexus Gene Lab Corp. is an emerging molecular diagnostics company. The Company is focused on the application of functional genomics to enable early diagnosis and personalized health management. The Company's wholly owned subsidiaries include Bionexus Gene Lab Sdn. Bhd. (Bionexus Malaysia) and Chemrex Sdn. Bhd. (Chemrex). BioNexus Malaysia owns algorithm software, technology and know-how related to the detection of common diseases through blood analysis which it uses in its business. Its non-invasive blood screening tests analyze changes in ribonucleic acid (RNA) to detect the risk potentiality of approximately 11 different diseases. These diseases include cancers, bowel diseases and osteoarthritis. Chemrex is a wholesaler of industrial chemicals for the manufacture of industrial, medical, appliance, aero, automotive, mechanical and electronic industries in Asia Pacific region.
Contact Information
- Headquarters
- Tower B, Vertical Business Suite, 10-2,KUALA LUMPUR, Malaysia 59200
- Phone
- ---
- Fax
- ---
Executives
- Chairman of the Board
- Soo Kow Lai
- President, Director
- Chi Yuen Leong
- Chief Executive Officer, Director
- Chan Chong Wong
- Chief Financial Officer, Principal Accounting Officer
- Wei Li Leong
- Chief Operating Officer, Director
- Liong Tai Tan
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $112.9M |
|---|---|
Revenue (TTM) | $11.3M |
Shares Outstanding | 173.7M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $0.00 |
Book Value | $0.04 |
P/E Ratio | -843.6x |
Price/Sales (TTM) | 10.0 |
Price/Cash Flow (TTM) | --- |
Operating Margin | 0.18% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
